Filing Details

Accession Number:
0001493152-23-011314
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-06 20:18:09
Reporting Period:
2023-04-03
Accepted Time:
2023-04-06 20:18:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1552189 Panacea Life Sciences Holdings Inc. PLSH Medicinal Chemicals & Botanical Products (2833) 271085858
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1866792 Leslie Buttorff 16194 W 45Th Drive
Golden CO 80403
Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-04-03 1,000 $0.36 710,949 No 4 P Direct
Common Stock Acquisiton 2023-04-04 3,200 $0.35 714,149 No 4 P Direct
Common Stock Acquisiton 2023-04-05 2,500 $0.33 716,649 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 7,297,627 Indirect Held by J&N Real Estate Company, LLC
Series C Preferred Stock 1,000,000 Direct
Series C-1 Preferred Stock 10,000 Direct
Series C-2 Preferred Stock 100 Direct
Series D Preferred Stock 10,000 Indirect Held by J&N Real Estate Company LLC